BeStock  
Stocks › Biotechnology › INSM

Insmed INSM

US equityMarket cap rank #631Biotechnology
$141.33 −$3.13 (-2.17%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $142.81 +1.05%
Open$143.27
Prev close$144.46
Day range$140.99 – $150.00
Volume6.22M
Market cap$31.01B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$524.43M+268.4% YoY
Operating profit-$81.83M+68.7% YoY
Net profit-$100.32M+72.9% YoY
Diluted EPS-$0.46+73.7% YoY
Free cash flow-$42.09M+81.1% YoY
Operating cash flow-$36.46M

Revenue, last 8 quarters

$104.4MDec '24$92.8MMar '25$107.4MJun '25$142.3MSep '25$263.8MDec '25$306.0MMar '26$425.5MJun '26$524.4MSep '26

Net profit, last 8 quarters

$-235.5MDec '24$-256.6MMar '25$-321.7MJun '25$-370.0MSep '25$-328.5MDec '25$-163.6MMar '26$-13.2MJun '26$-100.3MSep '26

Diluted EPS by quarter

-1.32Dec '24-1.42Mar '25-1.70Jun '25-1.75Sep '25-1.54Dec '25-0.76Mar '26-0.06Jun '26-0.46Sep '26

Free cash flow by quarter

$-202.8MDec '24$-272.2MMar '25$-209.1MJun '25$-222.2MSep '25$-264.2MDec '25$-226.2MMar '26$-95.1MJun '26$-42.1MSep '26

Annual revenue

$164.4MFY20$188.5MFY21$245.4MFY22$305.2MFY23$363.7MFY24$606.4MFY25

Profitability & balance sheet

Gross margin84.4%
Operating margin-41.7%
Net margin-39.9%
Return on equity-72.5%
Return on assets-26.4%
Return on invested capital-39.6%
Current ratio2.86
Liabilities / assets67.4%
Cash & investments$1.15B
Total debt$572.90M
Net cash (debt)$573.73M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $524.43M $425.49M $305.96M $606.42M $263.84M
Total Operating Revenue $524.43M $425.49M $305.96M $606.42M $263.84M
Cost of Revenue $78.22M $67.21M $47.42M $122.94M $44.22M
Gross Profit $446.21M $358.27M $258.54M $483.49M $219.62M
Operating Expense $528.04M $459.58M $458.83M $1.48B $469.33M
Selling and Admin Expenses $253.03M $247.47M $247.26M $701.17M $212.48M
-General & Admin Expense $253.03M $247.47M $247.26M $701.17M $212.48M
Research & Development $269.96M $210.03M $209.49M $771.09M $254.91M
Depreciation & Amortization & Depletion $5.05M $2.08M $2.08M $6.00M $1.94M
-Depreciation & Amortization $5.05M $2.08M $2.08M $6.00M $1.94M
Operating Profit -$81.83M -$101.31M -$200.28M -$994.78M -$249.71M
Net Non-Operating Interest Income (Expense) -$20.41M -$20.27M -$20.08M -$83.80M -$20.60M
Non-Operating Interest Expense $18.93M $18.84M $18.70M $77.58M $19.22M
Total Other Finance Costs $1.48M $1.43M $1.38M $6.22M $1.38M
Other Income (Expense) $4.59M $110.21M $58.27M -$193.18M -$56.63M
Gain on Sale of Security $11.07M $10.98M $12.04M $60.66M $15.24M
Special Income (Charges) -$7.54M $99.76M $46.96M -$251.99M -$70.04M
-Less:Restructuring and Mergern & Acquisition $7.54M -$99.76M -$46.96M $251.99M $70.04M
Other Non-Operating Income (Expenses) $1.06M -$531,000.00 -$736,000.00 -$1.84M -$1.82M
Pretax Profit -$97.65M -$11.37M -$162.10M -$1.27B -$326.93M
Tax $2.67M $1.87M $1.47M $5.03M $1.55M
Net Profit -$100.32M -$13.24M -$163.56M -$1.28B -$328.49M
Profit from Continuing Operations -$100.32M -$13.24M -$163.56M -$1.28B -$328.49M
Net Income to Parent Company -$100.32M -$13.24M -$163.56M -$1.28B -$328.49M
Net Income to Common Stockholders -$100.32M -$13.24M -$163.56M -$1.28B -$328.49M
Basic EPS -$0.46 -$0.06 -$0.76 -$6.42 -$1.54
Diluted EPS -$0.46 -$0.06 -$0.76 -$6.42 -$1.54
Non-Operating Interest Income – – – $0.00 $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $2.23B $2.10B $2.08B $2.26B $2.26B
Total Current Assets $1.71B $1.63B $1.61B $1.79B $1.79B
Cash and Cash Equivalents & Short-Term Investments $1.15B $1.16B $1.22B $1.43B $1.43B
-Cash and Cash Equivalents $396.56M $544.77M $582.19M $510.45M $510.45M
-Short Term Investments $750.06M $615.55M $641.33M $919.60M $919.60M
Receivables $259.27M $215.33M $178.56M $140.86M $140.86M
-Accounts Receivable $259.27M $215.33M $178.56M $140.86M $140.86M
Inventory $163.95M $142.38M $132.91M $132.07M $132.07M
Other Current Assets $136.67M $115.90M $78.20M $91.24M $91.24M
Total Non-Current Assets $519.55M $468.65M $462.69M $470.35M $470.35M
Net PPE $139.49M $134.60M $131.73M $139.21M $139.21M
-Gross PPE $209.57M $201.30M $195.33M $199.97M $199.97M
-Accumulated Depreciation -$70.08M -$66.70M -$63.59M -$60.76M -$60.76M
Goodwill and Other Intangible Assets $274.55M $229.60M $231.68M $233.76M $233.76M
-Goodwill $136.11M $136.11M $136.11M $136.11M $136.11M
-Other Intangible Assets $138.44M $93.49M $95.57M $97.65M $97.65M
Other Non-Current Assets $105.51M $104.44M $99.28M $97.38M $97.38M
Total Liabilities $1.50B $1.35B $1.37B $1.53B $1.53B
Total Current Liabilities $596.58M $438.74M $361.01M $468.87M $468.87M
Payables $148.62M $128.94M $102.64M $103.46M $103.46M
-Accounts Payable $84.30M $74.56M $73.38M $79.91M $79.91M
-Other Payable $64.32M $54.39M $29.26M $23.55M $23.55M
Current Accrued Expenses $348.51M $238.41M $203.93M $241.09M $241.09M
Short-Term Debt and Capital Lease Obligation $11.81M $9.82M $8.45M $12.81M $12.81M
-Current Capital Lease Obligation $11.81M $9.82M $8.45M $12.81M $12.81M
Other Current Liabilities $10.23M – – – –
Total Non-Current Liabilities $903.27M $906.33M $1.01B $1.06B $1.06B
Long Term Debt and Capital Lease Obligation $572.90M $570.07M $571.87M $573.86M $573.86M
-Long Term Debt $544.86M $543.51M $542.22M $540.96M $540.96M
-Long Term Capital Lease Obligation $28.04M $26.55M $29.66M $32.89M $32.89M
Other Non-Current Liabilities $330.37M $336.26M $438.13M $482.85M $482.85M
Total Equity $726.21M $757.49M $704.85M $738.98M $738.98M
Stockholders' Equity $726.21M $757.49M $704.85M $738.98M $738.98M
Capital Stock $2.19M $2.18M $2.17M $2.14M $2.14M
-Common Stock $2.19M $2.18M $2.17M $2.14M $2.14M
Additional Paid-In Capital $6.64B $6.57B $6.50B $6.37B $6.37B
Retained Earnings -$5.91B -$5.81B -$5.80B -$5.64B -$5.64B
Gains/Losses Not Affecting Retained Earnings -$40,000.00 -$3.37M $4,000.00 $1.46M $1.46M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$36.46M -$88.83M -$222.74M -$935.01M -$247.60M
Net cash flow from continuing operations -$36.46M -$88.83M -$222.74M -$935.01M -$247.60M
Net Income from Continuing Operations -$100.32M -$13.24M -$163.56M -$1.28B -$328.49M
Depreciation & Depletion & Amortization $8.40M $5.26M $5.02M $16.45M $5.56M
Other Non-Cash Items $15.60M -$91.71M -$39.22M $291.25M $84.33M
Change in Working Capital $3.47M -$24.93M -$64.21M -$80.30M -$37.64M
-Change in Receivables -$43.10M -$37.16M -$38.19M -$88.31M -$77.30M
-Change in Inventory -$18.00M -$12.97M -$1.89M -$31.52M -$11.76M
-Change in Prepaid Assets -$20.56M -$37.64M $12.59M -$53.43M -$26.22M
-Change in Payables and Accrued Expense $87.07M $68.82M -$33.88M $100.07M $90.35M
-Change in Other Current Assets -$1.16M -$5.23M -$2.36M -$2.12M -$11.79M
-Change in Other Current Liabilities -$769,000.00 -$744,000.00 -$497,000.00 -$4.99M -$914,000.00
Net cash flow from investing -$135.65M $24.51M $265.52M -$64.58M $389.41M
Net Cash Flow from Continuing Investing Activities -$135.65M $24.51M $265.52M -$64.58M $389.41M
Net PPE Purchase and Sale -$5.63M -$6.26M -$3.48M -$32.56M -$16.59M
Net Investment Purchase and Sale -$130.02M $30.77M $284.00M -$2.01M $436.00M
Net Other Investing Changes $0.00 $0.00 -$15.00M -$30.00M –
Financing Cash Flow $23.64M $27.18M $29.51M $954.07M $33.86M
Net Cash Flow from Continuing Financing Activities $23.64M $27.18M $29.51M $954.07M $33.86M
Net Issuance Payments Of Debt -$843,000.00 -$827,000.00 -$799,000.00 -$4.93M -$776,000.00
Net Common Stock Issuance $0.00 – – $823.28M $0.00
Proceeds from Stock Option Exercised $24.48M $28.01M $30.31M $135.72M $34.64M
Ending Cash Balance $396.56M $544.77M $582.19M $510.45M $510.45M
Net Change in Cash -$148.47M -$37.14M $72.30M -$45.52M $175.67M
Beginning Cash Balance $544.77M $582.19M $510.45M $555.03M $334.76M
Effect of Exchange Rate Changes $269,000.00 -$287,000.00 -$553,000.00 $931,000.00 $7,000.00
Free Cash Flow -$42.09M -$95.09M -$226.22M -$967.58M -$264.19M

Discussion

No comments yet — be the first to weigh in on INSM.

Sign in to join the discussion.

Scroll to Top